{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:08:41Z","timestamp":1696324121562},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1053\/j.ackd.2009.08.014","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T15:11:42Z","timestamp":1260544302000},"page":"102-110","source":"Crossref","is-referenced-by-count":7,"title":["Management of HIV-Infected Patients With ESRD"],"prefix":"10.1053","volume":"17","author":[{"given":"James E.","family":"Novak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda A.","family":"Szczech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2009.08.014_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-143-1-200507050-00008","article-title":"Screening for HIV: recommendation statement","volume":"143","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ackd.2009.08.014_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0002-9343(00)00583-0","article-title":"Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches","volume":"109","author":"Mylonakis","year":"2000","journal-title":"Am J Med"},{"key":"10.1053\/j.ackd.2009.08.014_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0272-6386(99)70121-6","article-title":"Anti-HIV indeterminate western blot in dialysis patients: a long-term follow-up","volume":"34","author":"Vardinon","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2009.08.014_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/08860220701260644","article-title":"Human immunodeficiency virus (HIV) infection screening in a dialysis unit","volume":"29","author":"Chou","year":"2007","journal-title":"Ren Fail"},{"key":"10.1053\/j.ackd.2009.08.014_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0002-9343(91)90638-E","article-title":"Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis. The Cooperative Dialysis Study Group","volume":"90","author":"Marcus","year":"1991","journal-title":"Am J Med"},{"key":"10.1053\/j.ackd.2009.08.014_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0272-6386(12)80901-2","article-title":"Activated and regulatory T lymphocyte populations in chronic hemodialysis patients","volume":"24","author":"Rabb","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2009.08.014_bib7","first-page":"40","article-title":"Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients","volume":"51","author":"Ahuja","year":"1999","journal-title":"Clin Nephrol"},{"issue":"Suppl 1","key":"10.1053\/j.ackd.2009.08.014_bib8","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1086\/425272","article-title":"Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection","volume":"191","author":"Celum","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1053\/j.ackd.2009.08.014_bib9","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons\u20132002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America","volume":"51","author":"Kaplan","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1053\/j.ackd.2009.08.014_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1523-1755.2005.00180.x","article-title":"Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis","volume":"67","author":"Ahuja","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2009.08.014_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000081041","article-title":"Dialyzing a patient with human immunodeficiency virus infection: what a nephrologist needs to know","volume":"24","author":"Mandayam","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ackd.2009.08.014_bib12","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/bmj.322.7298.1350","article-title":"ABC of AIDS: Treatment of infections","volume":"322","author":"Weller","year":"2001","journal-title":"BMJ"},{"key":"10.1053\/j.ackd.2009.08.014_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/ajkd.2000.16196","article-title":"Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients","volume":"36","author":"Ahuja","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2009.08.014_bib14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2215\/CJN.02211205","article-title":"Outcome and prognosis factors in HIV-infected hemodialysis patients","volume":"1","author":"Tourret","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2009.08.014_bib15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.ASN.0000062963.56513.28","article-title":"Determinants of survival among HIV-infected chronic dialysis patients","volume":"14","author":"Rodriguez","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2009.08.014_bib16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.ASN.0000127987.19470.3A","article-title":"Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression","volume":"15","author":"Abbott","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2009.08.014_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel","volume":"296","author":"Hammer","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.ackd.2009.08.014_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11904-009-0009-9","article-title":"Newer antiretroviral agents and how to use them","volume":"6","author":"Kim","year":"2009","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1053\/j.ackd.2009.08.014_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/315683","article-title":"In vivo antagonism with zidovudine plus stavudine combination therapy","volume":"182","author":"Havlir","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1053\/j.ackd.2009.08.014_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.104.075416","article-title":"Mechanism-based inactivation of CYP3A by HIV protease inhibitors","volume":"312","author":"Ernest","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1053\/j.ackd.2009.08.014_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1525-139X.2003.16047.x","article-title":"Human immunodeficiency virus infection in end-stage renal disease patients","volume":"16","author":"Rao","year":"2003","journal-title":"Semin Dial"},{"key":"10.1053\/j.ackd.2009.08.014_bib22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/430257","article-title":"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America","volume":"40","author":"Gupta","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.ackd.2009.08.014_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.293.7.817","article-title":"Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART","volume":"293","author":"Nettles","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.ackd.2009.08.014_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/0272-6386(95)90573-1","article-title":"The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis","volume":"25","author":"Shrivastava","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2009.08.014_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.autrev.2004.10.004","article-title":"Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia","volume":"4","author":"Mouthon","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.ackd.2009.08.014_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2009.08.014_bib27","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/jn\/137.10.2317","article-title":"Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression","volume":"137","author":"Kupka","year":"2007","journal-title":"J Nutr"},{"key":"10.1053\/j.ackd.2009.08.014_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.06.008","article-title":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target","volume":"50","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2009.08.014_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2369-4-5","article-title":"HIVAN and medication use in chronic dialysis patients in the United States: Analysis of the USRDS DMMS Wave 2 study","volume":"4","author":"Abbott","year":"2003","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ackd.2009.08.014_bib30","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1210\/jc.83.11.3832","article-title":"Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis","volume":"83","author":"Haug","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.ackd.2009.08.014_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0190-9622(92)70080-Y","article-title":"Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease","volume":"26","author":"Cockerell","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.ackd.2009.08.014_bib32","first-page":"77","article-title":"Calciphylaxis in a continuous ambulatory peritoneal dialysis patient after graft failure of cadaveric kidney transplantation","volume":"15","author":"Wang","year":"2001","journal-title":"Acta Nephrol"},{"key":"10.1053\/j.ackd.2009.08.014_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0196-6553(95)90057-8","article-title":"The risks of occupational exposure and infection by human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in the dialysis setting. Italian Multicenter Study on Nosocomial and Occupational Risk of Infections in Dialysis","volume":"23","author":"Petrosillo","year":"1995","journal-title":"Am J Infect Control"},{"key":"10.1053\/j.ackd.2009.08.014_bib34","first-page":"1","article-title":"Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis","volume":"50","author":"Updated","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"10.1053\/j.ackd.2009.08.014_bib35","first-page":"404","article-title":"HIV transmission in a dialysis center\u2013Colombia, 1991-1993","volume":"44","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/j.ackd.2009.08.014_bib36","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"10.1053\/j.ackd.2009.08.014_bib37","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/ki.1996.482","article-title":"HIV-1 survival kinetics in peritoneal dialysis effluent","volume":"50","author":"Farzadegan","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2009.08.014_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1525-139x.2000.00084-3.x","article-title":"Characteristics of peritonitis in HIV-positive PD patients","volume":"13","author":"Sreedhara","year":"2000","journal-title":"Semin Dial"},{"key":"10.1053\/j.ackd.2009.08.014_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ki.1993.230","article-title":"Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis","volume":"44","author":"Tebben","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2009.08.014_bib40","first-page":"159","article-title":"Survival experience of peritoneal dialysis patients with human immunodeficiency virus: a 17-year retrospective study","volume":"21","author":"Khanna","year":"2005","journal-title":"Adv Perit Dial"},{"key":"10.1053\/j.ackd.2009.08.014_bib41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ndt\/gfl629","article-title":"Arteriovenous access outcomes in haemodialysis patients with HIV infection","volume":"22","author":"Mitchell","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2009.08.014_bib42","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/0741-5214(92)90053-B","article-title":"The influence of human immunodeficiency virus infection and intravenous drug abuse on complications of hemodialysis access surgery","volume":"16","author":"Brock","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.ackd.2009.08.014_bib43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/000313480206801216","article-title":"Complications of hemodialysis access in HIV-positive patients","volume":"68","author":"Gorski","year":"2002","journal-title":"Am Surg"},{"key":"10.1053\/j.ackd.2009.08.014_bib44","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/1538574407308208","article-title":"Use of the Vectra polyetherurethaneurea graft for dialysis access in HIV-positive patients with end-stage renal disease","volume":"41","author":"Schild","year":"2007","journal-title":"Vasc Endovascular Surg"},{"key":"10.1053\/j.ackd.2009.08.014_bib45","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1681\/ASN.V11112122","article-title":"Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus","volume":"11","author":"Mokrzycki","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2009.08.014_bib46","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/00002030-200206140-00019","article-title":"HIV-1 dynamics in haemodialysis patients","volume":"16","author":"Schwartz","year":"2002","journal-title":"AIDS"},{"key":"10.1053\/j.ackd.2009.08.014_bib47","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/S0041-1345(01)02569-6","article-title":"Solid organ transplantation in HIV-positive patients","volume":"33","author":"Stock","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1053\/j.ackd.2009.08.014_bib48","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/00002030-200409240-00008","article-title":"Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients","volume":"18","author":"Sankatsing","year":"2004","journal-title":"AIDS"},{"key":"10.1053\/j.ackd.2009.08.014_bib49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00003088-200443120-00004","article-title":"Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools","volume":"43","author":"Sankatsing","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1053\/j.ackd.2009.08.014_bib50","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1523-1755.2004.00772.x","article-title":"Antiretroviral and immunosuppressive drug-drug interactions: an update","volume":"66","author":"Izzedine","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2009.08.014_bib51","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2006.01238.x","article-title":"Thymoglobulin-associated Cd4 + T-cell depletion and infection risk in HIV-infected renal transplant recipients","volume":"6","author":"Carter","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ackd.2009.08.014_bib52","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(00)04898-4","article-title":"CC chemokine receptor 5 and renal-transplant survival","volume":"357","author":"Fischereder","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2009.08.014_bib53","first-page":"669","article-title":"Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS","volume":"8","author":"Meanwell","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1053\/j.ackd.2009.08.014_bib54","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1089\/aid.2007.0015","article-title":"Effect of thymoglobulin induction on HIV-infected renal transplant recipients: Differences between HIV-positive and HIV-negative patients","volume":"23","author":"Trullas","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1053\/j.ackd.2009.08.014_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","article-title":"HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes","volume":"8","author":"Roland","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ackd.2009.08.014_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/TP.0b013e318177884e","article-title":"Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates","volume":"86","author":"Gruber","year":"2008","journal-title":"Transplantation"},{"key":"10.1053\/j.ackd.2009.08.014_bib57","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1097\/QAD.0b013e32830f4c8d","article-title":"Combined liver-kidney transplantation in an HIV-HCV-coinfected patient with haemophilia","volume":"22","author":"Ballarin","year":"2008","journal-title":"AIDS"},{"key":"10.1053\/j.ackd.2009.08.014_bib58","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/AAC.01602-06","article-title":"Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro","volume":"51","author":"Heredia","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.ackd.2009.08.014_bib59","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jhep.2005.08.005","article-title":"Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis","volume":"43","author":"Samonakis","year":"2005","journal-title":"J Hepatol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559509001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559509001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T21:33:36Z","timestamp":1685223216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559509001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1548559509001736"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2009.08.014","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}